Free Trial

Globus Medical (GMED) Earnings Date, Estimates & Call Transcripts

Globus Medical logo
$81.10 0.00 (0.00%)
(As of 11/15/2024 ET)

Globus Medical Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 18Estimated
Actual EPS
(Nov. 5)
$0.83 Beat By $0.18
Consensus EPS
(Nov. 5)
$0.65

Globus Medical released Q3 2024 earnings on November 5, 2024, reporting an EPS of $0.83, which beat the consensus estimate of $0.65 by $0.18. Quarterly revenue rose 63.1% year-over-year to $625.71 million, above analyst estimates of $604.69 million. With a trailing EPS of $0.67 and a P/E Ratio of 121.04, Globus Medical's earnings are expected to grow 15.10% next year, from $2.98 to $3.43 per share.

GMED Upcoming Earnings

Globus Medical's next earnings date is estimated for Tuesday, February 18, 2025, based off prior year's reporting schedules.

Get Globus Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Globus Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GMED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GMED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Globus Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.49$0.56$0.53 
Q2 20242$0.68$0.73$0.71 
Q3 20242$0.63$0.65$0.64 
Q4 20242$0.72$0.79$0.76 
FY 20248$2.52$2.73$2.63 
Q1 20252$0.77$0.80$0.79 
Q2 20252$0.81$0.81$0.81 
Q3 20252$0.81$0.83$0.82 
Q4 20252$0.82$0.91$0.87 
FY 20258$3.21$3.35$3.28 
Q1 20261$0.85$0.85$0.85 
Q2 20261$0.91$0.91$0.91 
Q3 20261$1.03$1.03$1.03 

Globus Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/18/2025
(Estimated)
------- 
11/5/2024Q3 2024$0.65$0.83+$0.18$1.28$604.69M$625.71M    
8/6/2024Q2 2024$0.68$0.75+$0.07$1.27$615.33M$629.69M      
5/7/2024Q1 2024$0.55$0.72+$0.17$1.49$586.82M$606.67M      
2/20/2024Q4 2023$0.59$0.60+$0.01$1.09$608.21M$616.53M      
11/7/2023Q3 2023$0.54$0.57+$0.03$1.13$306.78M$383.60M      
8/3/2023Q2 2023$0.60$0.63+$0.03$0.69$279.54M$291.62M      
5/4/2023Q1 2023$0.51$0.53+$0.02$0.58$254.05M$276.90M      
2/21/2023Q4 2022$0.55$0.59+$0.04$0.69$276.40M$274.50M      

Globus Medical Earnings - Frequently Asked Questions

Globus Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates. Learn more on GMED's earnings history.

Globus Medical issued an update on its FY 2024 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of 2.900-3.000 for the period, compared to the consensus estimate of 2.850. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion.

In the previous quarter, Globus Medical (NYSE:GMED) reported $0.83 earnings per share (EPS) to beat the analysts' consensus estimate of $0.65 by $0.18. Learn more on analysts' earnings estimate vs. GMED's actual earnings.

The conference call for Globus Medical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Globus Medical's latest earnings report can be read online.
Read Transcript

Globus Medical (NYSE:GMED) has a recorded annual revenue of $1.57 billion.

Globus Medical (NYSE:GMED) has a recorded net income of $122.87 million. GMED has generated $0.67 earnings per share over the last four quarters.

Globus Medical (NYSE:GMED) has a trailing price-to-earnings ratio of 121.04 and a forward price-to-earnings ratio of 27.21. The price/earnings-to-growth ratio is 1.97.

Globus Medical's earnings are expected to grow from $2.98 per share to $3.43 per share in the next year, which is a 15.10% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:GMED) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners